Literature DB >> 20628405

The iron-chelating potential of silybin in patients with hereditary haemochromatosis.

C Hutchinson1, A Bomford, C A Geissler.   

Abstract

Milk thistle contains silybin, which is a potential iron chelator. We aimed to determine whether silybin reduced iron absorption in patients with hereditary haemochromatosis. In this crossover study, on three separate occasions, 10 patients who were homozygous for the C282Y mutation in the HFE gene (and fully treated) consumed a vegetarian meal containing 13.9 mg iron with: 200 ml water; 200 ml water and 140 mg silybin (Legalon Forte); or 200 ml tea. Blood was drawn once before, then 0.5, 1, 2, 3 and 4 h after the meal. Consumption of silybin with a meal resulted in a reduction in the postprandial increase in serum iron (AUC±s.e.) compared with water (silybin 1726.6±346.8 versus water 2988.8±167; P<0.05) and tea (silybin 1726.6±346.8 versus tea 2099.3±223.3; P<0.05). In conclusion, silybin has the potential to reduce iron absorption, and this deserves further investigation, as silybin could be an adjunct in the treatment of haemochromatosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628405      PMCID: PMC3308202          DOI: 10.1038/ejcn.2010.136

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  9 in total

1.  Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C.

Authors:  Julie M Bares; Jose Berger; James E Nelson; Donald J Messner; Sandra Schildt; Leanna J Standish; Kris V Kowdley
Journal:  J Clin Gastroenterol       Date:  2008-09       Impact factor: 3.062

2.  Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages.

Authors:  R F Hurrell; M Reddy; J D Cook
Journal:  Br J Nutr       Date:  1999-04       Impact factor: 3.718

3.  Silybin, a new iron-chelating agent.

Authors:  M Borsari; C Gabbi; F Ghelfi; R Grandi; M Saladini; S Severi; F Borella
Journal:  J Inorg Biochem       Date:  2001-06       Impact factor: 4.155

4.  Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis.

Authors:  J P Kaltwasser; E Werner; K Schalk; C Hansen; R Gottschalk; C Seidl
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

5.  Vitamin C, the common cold, and iron absorption.

Authors:  J D Cook; E R Monsen
Journal:  Am J Clin Nutr       Date:  1977-02       Impact factor: 7.045

6.  Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.

Authors:  Marjan Gharagozloo; Behjat Moayedi; Maryam Zakerinia; Mehrdad Hamidi; Mehran Karimi; Mohammad Maracy; Zahra Amirghofran
Journal:  Fundam Clin Pharmacol       Date:  2009-05-07       Impact factor: 2.748

7.  The validation of using serum iron increase to measure iron absorption in human subjects.

Authors:  Michael Hoppe; Lena Hulthén; Leif Hallberg
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

8.  Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.

Authors:  Carol Hutchinson; Catherine A Geissler; Jonathan J Powell; Adrian Bomford
Journal:  Gut       Date:  2007-03-07       Impact factor: 23.059

9.  Serum iron curves can be used to estimate dietary iron bioavailability in humans.

Authors:  Rana E Conway; Catherine A Geissler; Robert C Hider; Richard P H Thompson; Jonathan J Powell
Journal:  J Nutr       Date:  2006-07       Impact factor: 4.798

  9 in total
  12 in total

Review 1.  Clinically Relevant Herb-Micronutrient Interactions: When Botanicals, Minerals, and Vitamins Collide.

Authors:  Bill J Gurley; Alyssa Tonsing-Carter; Sheila L Thomas; E Kim Fifer
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

Review 2.  Pharmacology of iron transport.

Authors:  Shaina L Byrne; Divya Krishnamurthy; Marianne Wessling-Resnick
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

Review 3.  A comprehensive review on phytochemicals for fatty liver: are they potential adjuvants?

Authors:  Taís Menezes do Moinho; Sandro Leão Matos; Carla R O Carvalho
Journal:  J Mol Med (Berl)       Date:  2022-01-07       Impact factor: 4.599

Review 4.  Antioxidants in liver health.

Authors:  Sael Casas-Grajales; Pablo Muriel
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

5.  Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Behjat Alsaadat Moaeidi; Fatemeh Eshraghi-Jazi; Ardeshir Talebi; Hamid Nasri; Shahrzad Baradaran; Marjan Gharagozloo; Tahereh Safari; Maryam Haghighi
Journal:  Int J Prev Med       Date:  2013-03

Review 6.  From Environment to Genome and Back: A Lesson from HFE Mutations.

Authors:  Raffaela Rametta; Marica Meroni; Paola Dongiovanni
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 7.  Natural Antioxidants in Anemia Treatment.

Authors:  Coralia Cotoraci; Alina Ciceu; Alciona Sasu; Anca Hermenean
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

8.  Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model.

Authors:  Mitra Navidi-Shishaone; Soheila Mohhebi; Mehdi Nematbakhsh; Shahla Roozbehani; Ardeshir Talebi; Zahra Pezeshki; Fatemeh Eshraghi-Jazi; Safoora Mazaheri; Sohiela Shirdavani; Marjan Gharagozloo; Behjat Alsaadat Moaeidi
Journal:  Int J Prev Med       Date:  2014-01

Review 9.  Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015.

Authors:  Hadi Darvishi Khezri; Ebrahim Salehifar; Mehrnoush Kosaryan; Aily Aliasgharian; Hossein Jalali; Arash Hadian Amree
Journal:  Adv Pharmacol Sci       Date:  2016-02-21

Review 10.  Management of Iron Overload in Resource Poor Nations: A Systematic Review of Phlebotomy and Natural Chelators.

Authors:  Orish Ebere Orisakwe; Cecilia Nwadiuto Amadi; Chiara Frazzoli
Journal:  J Toxicol       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.